| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 07/07/2005 | WO2005060999A2 Detection of cd20 in therapy of autoimmune diseases |
| 07/07/2005 | WO2005060998A2 Methods of modulating cytokine activity; related reagents |
| 07/07/2005 | WO2005060997A2 Medicament comprising inhibitors of long pentraxin ptx3 |
| 07/07/2005 | WO2005060764A1 Method for improving body weight uniformity and increasing carcass yield in animals |
| 07/07/2005 | WO2005060713A2 Method of inhibiting candida-related infections using donor selected or donor stimulated immunoglobulin compositions |
| 07/07/2005 | WO2005060675A2 Novel spliced 5-ht1a receptors and methods, kits, and uses relating thereto |
| 07/07/2005 | WO2005060642A2 Rationally designed antibodies |
| 07/07/2005 | WO2005060641A2 Engineered templates and their use in single primer amplification |
| 07/07/2005 | WO2005060520A2 ANTIBODIES AGAINST SARS-CoV AND METHODS OF USE THEREOF |
| 07/07/2005 | WO2005060457A2 Treatment of inflammatory bowel diseases with anti-ip-10 antibodies |
| 07/07/2005 | WO2005060375A2 Methods of therapy and diagnosis using targeting of cells that express killer cell immunoglobulin-like receptor-like protein |
| 07/07/2005 | WO2005060368A2 Humanized anti-ccr2 antibodies and methods of use |
| 07/07/2005 | WO2005050198A3 Metadherin polypeptides, encoding nucleic acids and methods of use |
| 07/07/2005 | WO2005038006A3 Chimeric metabotropic glutamate receptors and uses thereof |
| 07/07/2005 | WO2005035720A3 Methods and use of binding components for improving assay specificity |
| 07/07/2005 | WO2005030806A3 Norovirus monoclonal antibodies and peptides |
| 07/07/2005 | WO2005028508A3 Nogo-a binding with enhanced affinity and pharmaceutical use thereof |
| 07/07/2005 | WO2005026205A3 Genetic products which are differentially expressed in tumours and use thereof |
| 07/07/2005 | WO2005020785A3 Discovery of the microorganism that causes the human autoimmune disease, primary biliary cirrhosis |
| 07/07/2005 | WO2005016266A3 Methods for treating cardiovascular disease using a soluble ctla4 molecule |
| 07/07/2005 | WO2005000894A3 Binding molecules for the treatment of myeloid cell malignancies |
| 07/07/2005 | WO2004080425A3 Polypeptide compounds for inhibiting angiogenesis and tumor growth |
| 07/07/2005 | WO2004078909A3 Identification of antigen epitopes |
| 07/07/2005 | WO2004071439A3 Immunoglobulin formulation and method of preparation thereof |
| 07/07/2005 | WO2004053064A3 Engineered fab'fragment anti-tumor necrosis factor alpha in combination with disease modifying anti-rheumatic drugs |
| 07/07/2005 | WO2004050849A8 Recombinant immunotoxin and use in treating tumors |
| 07/07/2005 | WO2003089583A3 Tissue specific genes and gene clusters |
| 07/07/2005 | WO2003083069A8 Activation of tumor-reactive lymphocytes via antibodies or genes recognizing cd3 or 4-1bb |
| 07/07/2005 | WO2003061571A3 Combination il-2/anti-herz antibody therapy for cancers characterized by overexpression of the her2 receptor protein |
| 07/07/2005 | US20050149996 Generation of chicken cell lines from embryonic stem cells and germ cells |
| 07/07/2005 | US20050149994 Rapidly maturing fluorescent proteins and methods for using the same |
| 07/07/2005 | US20050148761 Genetic products of ashbya gossypii, associated with transmembrane transport |
| 07/07/2005 | US20050148596 Indinavir derivatives useful in immunoassay |
| 07/07/2005 | US20050148502 Compositions and methods for preventing and treating cancer via modulating ube1l, isg15 and/or ubp43 |
| 07/07/2005 | US20050148062 Transgenic microorganisms comprising apoptosis associated genes for use as tools in identifying modulators for prevention and treatment of cell proliferative disorders |
| 07/07/2005 | US20050148046 Reaction solution for cell-free protein synthesis, method of preparing the same, and protein synthesis method using the same |
| 07/07/2005 | US20050148041 Sandwich assay kits for detecting shigatoxin ctx3c |
| 07/07/2005 | US20050148039 Process and materials for the rapid detection of Streptococcus pneumoniae employing purified antigen-specific antibodies |
| 07/07/2005 | US20050148037 Method for examining WT1-related disease |
| 07/07/2005 | US20050148031 Using membrane traversing peptide conjugate comprising reporter element to transfer fluorescent molecules across cell membranes |
| 07/07/2005 | US20050148027 Very large scale immobilized polymer synthesis |
| 07/07/2005 | US20050148024 Using hormone peptides concentrations as diagnostic tools in detection of cardiovascular disorders |
| 07/07/2005 | US20050148020 ATM kinase compositions and methods |
| 07/07/2005 | US20050148014 Regulation of human P2Y1-like G protein-coupled receptor |
| 07/07/2005 | US20050148013 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof |
| 07/07/2005 | US20050148012 BPC-1: a secreted brain-specific protein expressed and secreted by prostate and bladder cancer cells |
| 07/07/2005 | US20050148002 Sequence of surface immobilized polymers utilizing microfluorescence detection |
| 07/07/2005 | US20050148001 Structure-based construction of human antibody library |
| 07/07/2005 | US20050147988 Recombinant protein for use as tool in detection of helicobacter infection; immunodiagnostics |
| 07/07/2005 | US20050147971 Biomolecule transduction motif mph-1-btm and the use thereof |
| 07/07/2005 | US20050147969 Genes associated with mast cell activation |
| 07/07/2005 | US20050147962 Display of dimeric proteins on phage |
| 07/07/2005 | US20050147618 comprising blood coagulation factors and segments of an immunoglobulin fragments, used for treating hemostatic disorders |
| 07/07/2005 | US20050147616 Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment |
| 07/07/2005 | US20050147614 Stable, humanized, high affinity antibodies against carcinoembryonic antigen, therapy |
| 07/07/2005 | US20050147613 using bispecific antibodies comprising an antibody having binding specificity which confers the ability to cross the blood-brain barrier, and a second antibody conferring the ability to bind to beta -amyloid epitopes, used for the treatment of Alzheimer's disease or Down's syndrome |
| 07/07/2005 | US20050147612 Antibodies that block receptor protein tyrosine kinase activation, methods of screening for and uses thereof |
| 07/07/2005 | US20050147610 Polypeptides comprising antigen binding domains for diagnosis, prevention and treatment of inflammation, skin, respiratory, kidney, cardiovascular, nervous system and pancreatic disorder |
| 07/07/2005 | US20050147607 administering interleukin antagonists, for prophylaxis of respiratory system disorders |
| 07/07/2005 | US20050147606 Acute myeloid leukemia therapy |
| 07/07/2005 | US20050147605 Antibodies against C3a Receptor |
| 07/07/2005 | US20050147604 Means and methods for diagnosing and treating affective disorders |
| 07/07/2005 | US20050147603 Employing nonimmunogenic blood products from patients with autoimmune disease |
| 07/07/2005 | CA2773169A1 Unsaturated fatty acid synthase gene originating in marchantiales plant and utilization of the same |
| 07/07/2005 | CA2688944A1 Humanized anti-ngf antibodies |
| 07/07/2005 | CA2648274A1 Unsaturated fatty acid synthase gene originating in marchantiales plant and utilization of the same |
| 07/07/2005 | CA2551796A1 Method for the humanization of antibodies and humanized antibodies thereby obtained |
| 07/07/2005 | CA2551546A1 Preventive/remedy for cancer |
| 07/07/2005 | CA2550489A1 Unsaturated fatty acid synthase gene originating in marchantiales plant and utilization of the same |
| 07/07/2005 | CA2549982A1 Engineered templates and their use in single primer amplification |
| 07/07/2005 | CA2549956A1 Nogo-a neutralising immunoglobulins for treatment of neurological diseases |
| 07/07/2005 | CA2549937A1 Human anti-idiotypic antibody fragments that mimic her-2/neu |
| 07/07/2005 | CA2549923A1 Purification of immunoglobulins |
| 07/07/2005 | CA2549306A1 Methods of modulating cytokine activity; related reagents |
| 07/07/2005 | CA2549237A1 Detection of cd20 in transplant rejection |
| 07/07/2005 | CA2549168A1 Method for improving body weight uniformity and increasing carcass yield in animals |
| 07/07/2005 | CA2549122A1 Detection of cd20 in therapy of autoimmune diseases |
| 07/07/2005 | CA2548452A1 Medicament comprising inhibitors of long pentraxin ptx3 |
| 07/07/2005 | CA2548065A1 Anti-igf-i receptor antibody |
| 07/07/2005 | CA2544562A1 Bispecific antibodies |
| 07/07/2005 | CA2529694A1 Humanized anti-ccr2 antibodies and methods of use therefor |
| 07/07/2005 | CA2522421A1 Methods of therapy and diagnosis using targeting of cells that express killer cell immunoglobulin-like receptor-like protein |
| 07/06/2005 | EP1550729A1 Target binding polypeptide comprising an IG-like VL domain linked to an IG-like VH domain |
| 07/06/2005 | EP1550720A1 Mutated androgen receptor, cancer cells expressing the same, method of constructing the same and use thereof |
| 07/06/2005 | EP1550673A1 Polyclonal antibodies, preparation method thereof and use of same |
| 07/06/2005 | EP1550460A1 Method for correcting immune responses and medicinal agent |
| 07/06/2005 | EP1550454A1 Extracorporeal photopheresis in combination with anti-TNF treatment |
| 07/06/2005 | EP1549951A2 Semaphorin-like proteins and methods of using same |
| 07/06/2005 | EP1549763A2 Prophylactic and therapeutic hiv aptamers |
| 07/06/2005 | EP1549748A1 Single chain recombinant t cell receptors |
| 07/06/2005 | EP1549741A1 Novel endothelial cells, antibodies directed against said cells and use thereof, in particular for screening angiogenesis inhibiting substances |
| 07/06/2005 | EP1549678A2 Hybridomas producing high levels of human sequence antibody |
| 07/06/2005 | EP1549673A2 Novel mhc ii associated peptides |
| 07/06/2005 | EP1549671A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 07/06/2005 | EP1549664A2 Murine ortholog of the human disrupted-in-schizophrenia 1 gene |
| 07/06/2005 | EP1549345A1 Bispecific anti-erb-b antibodies and their use in tumor therapy |
| 07/06/2005 | EP1549344A1 Pharmaceutical compositions directed to erb-b1 receptors |
| 07/06/2005 | EP1549343A2 Method for the treatment of nephritis using anti-pdgf-dd antibodies |
| 07/06/2005 | EP1549342A2 Isolation of immunoglobulin molecules that lack inter-heavy chain disulfide bonds |
| 07/06/2005 | EP1549341A2 Novel tissue factor targeted antibodies as anticoagulants |